BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32661705)

  • 1. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2.
    Wang J; Yao Y; Wang K; Li J; Chu T; Shen H
    Acta Diabetol; 2020 Dec; 57(12):1435-1443. PubMed ID: 32661705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircSLC16A12 Absence Inhibits High Glucose-Induced Dysfunction in Retinal Microvascular Endothelial Cells through Mediating miR-140-3p/FGF2 Axis in Diabetic Retinopathy.
    Wang S; Yu Q; Wang Y; Xu C; Niu G; Liu R
    Curr Eye Res; 2022 May; 47(5):759-769. PubMed ID: 35179428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway.
    Xue L; Xiong C; Li J; Ren Y; Zhang L; Jiao K; Chen C; Ding P
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33150936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis.
    Gong Y; Li X; Xie L
    Bioengineered; 2022 May; 13(5):11694-11705. PubMed ID: 35510503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
    Xia F; Sun JJ; Jiang YQ; Li CF
    J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3p/vascular endothelial growth factor C.
    Yan H; Yao P; Hu K; Li X; Li H
    J Diabetes Investig; 2021 Nov; 12(11):1948-1957. PubMed ID: 34137197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
    Yu L; Fu J; Yu N; Wu Y; Han N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hsa_circ_0004805/hsa_miR-149-5p/TGFB2 axis plays critical roles in the pathophysiology of diabetic retinopathy in vitro and in vivo.
    Shao J; Gu W; Ye L; Xin Y
    Mol Cell Endocrinol; 2023 Oct; 576():112042. PubMed ID: 37567360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
    Wang JJ; Wu KF; Wang DD
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circFTO upregulates transforming growth factor-alpha through sponging miR-148a-3p to regulate high glucose-induced ARPE-19 cells injury.
    Huang Y; Li X; Jiang L; Mo C; Luo M; Hu K
    Bioengineered; 2022 May; 13(5):11489-11502. PubMed ID: 35506311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
    Han N; Tian W; Yu N; Yu L
    J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-301a-3p promotes diabetic retinopathy via regulation of six-transmembrane epithelial antigen of prostate 4.
    Wang Y; Gao L; Li Z; Ma X
    Inflamm Res; 2021 Apr; 70(4):445-457. PubMed ID: 33609142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes.
    Wang S; Du S; Lv Y; Wang W; Zhang F
    IUBMB Life; 2020 Jul; 72(7):1433-1448. PubMed ID: 32150340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
    Liu X; Li J; Li X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-Regulation of circCOL1A2 Suppresses the Dysfunction of Diabetes-Related Retinal Microvascular Endothelial Cells via miR-646/FGF7 Axis.
    Cao H; Xu X; Wang K; Li C
    Curr Eye Res; 2022 Nov; 47(11):1525-1533. PubMed ID: 35924466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA TPTEP1 suppresses diabetic retinopathy by reducing oxidative stress and targeting the miR-489-3p/NRF2 axis.
    Wang X; Zhou X; Wang F; Zhang N; Zhang Y; Ao Z; He F
    Acta Biochim Pol; 2023 Feb; 70(1):45-50. PubMed ID: 36795778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.